ARID1A and ovarian carcinoma: Similarly, the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathway, which is related to the ARID1A pathway, may be abnormally activated in endometriosis-associated ovarian cancer.